The short version
18 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now — FDA lists the reason as “requirements related to complying with good manufacturing practices”.
Market view
carboplatin
58 marketed package NDCs · 18 active manufacturers
Most dispensed: 10 mg/mL · Injection, Solution · #1 vial, multi-dose/carton / 15 ml in 1 vial, multi-dose · 10 mg/mL · Injection, Solution · #1 vial, multi-dose/carton / 45 ml in 1 vial, multi-dose · 10 mg/mL · Injection, Solution · #1 vial, multi-dose/carton / 5 ml in 1 vial, multi-dose · 10 mg/mL · Injection, Solution · #1 vial, multi-dose/carton / 60 ml in 1 vial, multi-dose
What changed in the last 90 days
Every detected change for carboplatin, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- CarboplatinSep 3, 2026Being discontinuedby this manufacturerTeyro Labs plans to stop making its Carboplatin (Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial) — was in shortage18 companies market carboplatin · 8 have products in shortage
- CarboplatinAug 31, 2026Now in shortageby this manufacturerTeyro Labs's Carboplatin (Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial) is now in shortage — was planned for discontinuation18 companies market carboplatin · 8 have products in shortage
- CarboplatinAug 31, 2026Being discontinuedby this manufacturerTeyro Labs plans to stop making its Carboplatin (Injection, 600 mg/60 mL (10 mg/mL) Multiple Dose Vial) — was in shortage18 companies market carboplatin · 8 have products in shortage
- CarboplatinAug 31, 2026Now in shortageby this manufacturerTeyro Labs's Carboplatin (Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial) is now in shortage — was planned for discontinuation18 companies market carboplatin · 8 have products in shortage
- CarboplatinAug 28, 2026Being discontinuedby this manufacturerTeyro Labs plans to stop making its Carboplatin (Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial) — was in shortage18 companies market carboplatin · 8 have products in shortage
- CarboplatinAug 28, 2026Being discontinuedby this manufacturerTeyro Labs plans to stop making its Carboplatin (Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial) — was in shortage18 companies market carboplatin · 8 have products in shortage
- CarboplatinAug 27, 2026Now in shortageby this manufacturerTeyro Labs's Carboplatin (Injection, 50 mg/5 mL (10 mg/mL) Multiple Dose Vial) is now in shortage — was planned for discontinuation18 companies market carboplatin · 8 have products in shortage
- CarboplatinAug 27, 2026Now in shortageby this manufacturerTeyro Labs's Carboplatin (Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial) is now in shortage — was planned for discontinuation18 companies market carboplatin · 8 have products in shortage
- CarboplatinAug 23, 2026Now in shortageby this manufacturerTeyro Labs's Carboplatin (Injection, 150 mg/15 mL (10 mg/mL) Multiple Dose Vial) is now in shortage — was planned for discontinuation18 companies market carboplatin · 8 have products in shortage
- CarboplatinAug 22, 2026Being discontinuedby this manufacturerTeyro Labs plans to stop making its Carboplatin (Injection, 450 mg/45 mL (10 mg/mL) Multiple Dose Vial) — was in shortage18 companies market carboplatin · 8 have products in shortage
Same drug class
Other molecules FDA puts in Platinum-based Drug, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Carboplatin in shortage right now?
- Yes. FDA currently lists Carboplatin in shortage, with the reason given as "requirements related to complying with good manufacturing practices". This page is rebuilt every morning from FDA's shortage database.
- Who makes Carboplatin?
- 18 companies have marketed Carboplatin in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
Shortage reports for this molecule
- In shortage now — Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-12)Apr 28, 2023
- In shortage now — Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-31)Apr 28, 2023
- In shortage now — Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-33)Apr 28, 2023
- In shortage now — Carboplatin, Injection, 10 mg/1 mL (NDC 16729-295-34)Apr 28, 2023
- In shortage now — Kyxata, Injection, 500 mg/50 mL (10 mg/mL) (NDC 83831-142-50)Apr 28, 2023
- In shortage now — Kyxata, Injection, 80 mg/8 mL (10 mg/mL) (NDC 83831-141-08)Apr 28, 2023
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.